Insmed Inc (INSM)
24.92
-0.89
(-3.45%)
USD |
NASDAQ |
Apr 25, 16:00
Insmed Price: 24.92 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 25.44 | 25.44 | 24.81 | 24.92 | 1.207M |
Apr 24, 2024 | 25.58 | 25.96 | 25.34 | 25.81 | 2.741M |
Apr 23, 2024 | 25.03 | 25.82 | 24.56 | 25.27 | 2.130M |
Apr 22, 2024 | 24.37 | 25.14 | 23.55 | 24.11 | 3.276M |
Apr 19, 2024 | 24.86 | 25.87 | 23.52 | 24.32 | 5.535M |
Apr 18, 2024 | 26.07 | 26.31 | 24.77 | 24.80 | 2.300M |
Apr 17, 2024 | 26.24 | 26.54 | 25.85 | 26.18 | 1.211M |
Apr 16, 2024 | 26.87 | 26.98 | 26.11 | 26.15 | 1.985M |
Apr 15, 2024 | 27.09 | 27.22 | 26.40 | 26.82 | 2.035M |
Apr 12, 2024 | 28.39 | 28.46 | 26.95 | 27.25 | 2.639M |
Apr 11, 2024 | 28.69 | 28.69 | 28.00 | 28.56 | 1.002M |
Apr 10, 2024 | 27.59 | 28.43 | 27.26 | 28.39 | 1.147M |
Apr 09, 2024 | 28.20 | 28.33 | 27.73 | 28.01 | 1.194M |
Apr 08, 2024 | 27.65 | 28.14 | 27.56 | 28.11 | 983136.0 |
Apr 05, 2024 | 27.20 | 28.07 | 26.92 | 27.66 | 1.663M |
Apr 04, 2024 | 27.68 | 27.90 | 27.14 | 27.28 | 2.501M |
Apr 03, 2024 | 26.07 | 27.75 | 25.99 | 27.68 | 2.124M |
Apr 02, 2024 | 26.49 | 26.65 | 25.83 | 26.30 | 3.020M |
Apr 01, 2024 | 26.90 | 27.10 | 26.42 | 26.72 | 2.567M |
Mar 28, 2024 | 27.22 | 27.55 | 27.00 | 27.13 | 1.130M |
Mar 27, 2024 | 27.02 | 27.41 | 26.71 | 27.32 | 1.258M |
Mar 26, 2024 | 27.29 | 27.41 | 26.95 | 27.02 | 1.182M |
Mar 25, 2024 | 26.52 | 27.01 | 26.19 | 27.00 | 958544.0 |
Mar 22, 2024 | 26.57 | 26.61 | 26.02 | 26.43 | 967867.0 |
Mar 21, 2024 | 26.83 | 27.08 | 26.34 | 26.34 | 987342.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.63
Minimum
Mar 23 2020
44.30
Maximum
Feb 08 2021
25.22
Average
24.71
Median
Jun 13 2019
Price Benchmarks
NeuroMetrix Inc | 4.10 |
Intra-Cellular Therapies Inc | 72.13 |
Rhythm Pharmaceuticals Inc | 38.15 |
Amylyx Pharmaceuticals Inc | 1.785 |
AN2 Therapeutics Inc | 2.46 |
Price Related Metrics
PS Ratio | 11.46 |
PEG Ratio | -0.1264 |
Earnings Yield | -21.43% |
Market Cap | 3.700B |
PEGY Ratio | -0.1264 |